Literature DB >> 21821228

A video study of drop instillation in both glaucoma and retina patients with visual impairment.

Amy L Hennessy1, Joanne Katz, David Covert, Colleen A Kelly, Eric P Suan, Matthew A Speicher, Newman J Sund, Alan L Robin.   

Abstract

PURPOSE: To compare self-administration of drops in both visually impaired glaucoma subjects and retina subjects.
DESIGN: Prospective, observational study.
SETTING: Distinct glaucoma and retina practices. STUDY POPULATION: Subjects with glaucoma or retinal diseases with visual acuity of 20/60 or worse in 1 eye, significant field loss, or both. OBSERVATION PROCEDURES: Subjects were video recorded self-instilling a drop onto the worse eye. MAIN OUTCOME MEASURE: Proper instillation of eye drop onto ocular surface.
RESULTS: We included 409 subjects (205 glaucoma, 204 retina). Differences between the groups included the following: glaucoma subjects included fewer females (P = .05), included fewer white persons (P < .005), had worse visual acuity (P < .005), had less self-reported arthritis (P < .05), were younger (P < .005), and had more previous exposure to drop use (P < .005). Glaucoma subjects had more bilateral impairment (60% vs 42%; P < .0005). Retina subjects instilled more drops (1.7 vs 1.4; P = .02) and more frequently touched the bottle to the eye (47% vs 33%; P = .003). Of subjects claiming not to miss the eye, nearly one third from each group (P = .32) actually missed. Approximately one third of each group could not get a drop onto the eye (30% retina vs 29% glaucoma; P = .91). Among subjects placing 1 drop onto the eye without touching the adnexae, there was a trend for glaucoma patients to perform better, although both groups did poorly (success, 39% glaucoma vs 31% retina; P = .09).
CONCLUSIONS: Among visually impaired subjects, regardless of cause, drop administration was a problem. Both groups wasted drops, contaminated bottles, and had inaccurate perception of their abilities. This has implications for future therapeutic delivery systems.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821228     DOI: 10.1016/j.ajo.2011.05.015

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  26 in total

1.  A novel eye drop application monitor to assess patient compliance with a prescribed regimen: a pilot study.

Authors:  A M Eaton; G M Gordon; A Konowal; A Allen; M Allen; A Sgarlata; G Gao; H Wafapoor; R L Avery
Journal:  Eye (Lond)       Date:  2015-09-11       Impact factor: 3.775

2.  Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up.

Authors:  Paula Anne Newman-Casey; Taylor Blachley; Paul P Lee; Michele Heisler; Karen B Farris; Joshua D Stein
Journal:  Ophthalmology       Date:  2015-08-25       Impact factor: 12.079

3.  The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.

Authors:  Paula Anne Newman-Casey; Alan L Robin; Taylor Blachley; Karen Farris; Michele Heisler; Ken Resnicow; Paul P Lee
Journal:  Ophthalmology       Date:  2015-04-24       Impact factor: 12.079

4.  American Glaucoma Society Position Paper: Microinvasive Glaucoma Surgery.

Authors:  Ronald L Fellman; Cynthia Mattox; Kuldev Singh; Brian Flowers; Brian A Francis; Alan L Robin; Michelle R Butler; Manjool M Shah; JoAnn A Giaconi; Arsham Sheybani; Brian J Song; Joshua D Stein
Journal:  Ophthalmol Glaucoma       Date:  2020 Jan - Feb

5.  How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique.

Authors:  Robyn Sayner; Delesha M Carpenter; Alan L Robin; Susan J Blalock; Kelly W Muir; Michelle Vitko; Mary Elizabeth Hartnett; Scott D Lawrence; Annette L Giangiacomo; Gail Tudor; Jason A Goldsmith; Betsy Sleath
Journal:  Int J Pharm Pract       Date:  2015-08-25

6.  Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs.

Authors:  Jordana K Schmier; Carolyn K Hulme-Lowe; David W Covert
Journal:  Clin Ophthalmol       Date:  2014-06-10

7.  Glaucoma, "the silent thief of sight": patients' perspectives and health seeking behaviour in Bauchi, northern Nigeria.

Authors:  Mohammed Mahdi Abdull; Clare Chandler; Clare Gilbert
Journal:  BMC Ophthalmol       Date:  2016-04-21       Impact factor: 2.209

Review 8.  Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.

Authors:  Uday B Kompella; Rachel R Hartman; Madhoosudan A Patil
Journal:  Prog Retin Eye Res       Date:  2020-09-04       Impact factor: 21.198

9.  Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy.

Authors:  Kevin J Schneider; Cecilia N Hollenhorst; Autumn N Valicevic; Leslie M Niziol; Michele Heisler; David C Musch; Stephen M Cain; Paula-Anne Newman-Casey
Journal:  Ophthalmol Glaucoma       Date:  2020-08-08

10.  Ocular drug delivery for glaucoma management.

Authors:  Nathan Gooch; Sarah A Molokhia; Russell Condie; Randon Michael Burr; Bonnie Archer; Balamurali K Ambati; Barbara Wirostko
Journal:  Pharmaceutics       Date:  2012-03-08       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.